The univariate hazard ratio (HR) for a low expression of CD204+TAMs was 0.75 (1/0.75 = 1.33), indicating a 1.33 times significantly lower chance of tumour recurrence compared with patients with a high expression of CD204+TAMs (p = 0.039). Here, MSR1 is linked to neoplasm.